GENMAB A/S: Financial statements 2020
CVR: 21023884
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
GENMAB A/S (CVR 21023884) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 10,111,000,000 and a net result of DKK 4,758,000,000 compared with DKK 2,166,000,000 the year before. That is an increase of 88.4% compared with the year before. The profit margin was 47.1%. Equity in the 2020 report amounted to DKK 19,121,000,000. The solvency ratio was 90.4%.
- Revenue
- DKK 10,111,000,000
- Profit/Loss
- DKK 4,758,000,000
- Equity
- DKK 19,121,000,000
- Total Assets
- DKK 21,143,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 10.1 mia. | - | 4.8 mia. | 19.1 mia. | - |
| 2019 | 5.4 mia. | - | 2.2 mia. | 14 mia. | - |
| 2018 | 3 mia. | - | 1.5 mia. | 8 mia. | - |
| 2017 | 2.4 mia. | - | 1.1 mia. | 6.3 mia. | - |
| 2016 | 1.8 mia. | - | 1.2 mia. | 4.8 mia. | - |
Official annual report
How creditworthy is GENMAB A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
GENMAB A/S has published its interim report for the period January 1, 2020 – September 30, 2020.
GENMAB A/S has published its interim report for the period January 1, 2020 – June 30, 2020.
As of August 17, 2020, Rima Bawarshi Nassar has joined the board of directors of GENMAB A/S.
As of August 17, 2020, Daniel John Bruno has left the board of directors of GENMAB A/S.
As of August 16, 2020, Rima Bawarshi Nassar has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2020 – March 31, 2020.
GENMAB A/S has published its annual report for 2019. Revenue came to DKK 5,366,000,000, and the net result was DKK 2,166,000,000.
As of March 26, 2020, Pernille Lyngvold Erenbjerg has joined the board of directors of GENMAB A/S.
As of March 26, 2020, Deirdre Patrice Connelly has joined the board of directors of GENMAB A/S.
As of March 26, 2020, Jonathan Michael Peacock has joined the board of directors of GENMAB A/S.
About GENMAB A/S
GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC.. The company has 676 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.